In HCC, upregulation of PVRL1 stabilizes the surface expression of PVR, which interacts with the inhibitory receptor TIGIT on CD8+ effector memory T cells, suppressing antitumor immune responses and leading to resistance to PD-1 inhibitors [109]. The gene discussed is TIGIT; the disease is hepatocellular carcinoma.